Fig. 2: Overview of digital biomarker exploration and feature engineering for the ITA model development on the AF cohort. | npj Digital Medicine

Fig. 2: Overview of digital biomarker exploration and feature engineering for the ITA model development on the AF cohort.

From: A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19

Fig. 2

a Time-series plot of the deviation in digital biomarkers (ΔSteps and ΔRHR) in the detection window compared to baseline periods, between the participants diagnosed as COVID-19 positive and negative. The horizontal dashed line displays the baseline median and the confidence bounds show the 95% confidence intervals. b Heatmaps of steps and RHR features that are statistically significantly different (p value <0.05; unpaired t-tests) in a grid search with a different detection end date (DED) and detection window length (DWL) combinations, with green boxes showing p values <0.05 and gray boxes showing p values ≥0.05. The p values are adjusted with the Benjamini–Hochberg method for multiple hypothesis correction. c Summary of the significant features (p value <0.05; unpaired t-tests) from b, with each box showing the number of statistically significant features for the different combinations of DED and DWL. The intersection of the significant features across DWL of 3 and 5 days with a common DED of 1 day prior to the test date (as shown using the black rectangle) was used for the ITA model development. d Box plots comparing the distribution of the two most significant steps and RHR features between the participants diagnosed as COVID-19 positive and negative. The centerlines denote feature medians, bounds of boxes represent 25th and 75th percentiles, whiskers denote nonoutlier data range and the diamonds denote outlier values.

Back to article page